Skip to main content
AACE 2024 Annual Meeting Main banner

  1. Home

  • Thursday, May 9th
    11:45 AM – 12:00 PM CDT
    The Impact of Digital Twin Technology on HbA1c Reduction and ASCVD Risk in Participants Enrolled for Type 2 Diabetes Remission: Outcomes of RCCT At 1 Year
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Paramesh Shamanna, MD – Bangalore Diabetes Centre
    Cardiometabolic and Lipids
  • Thursday, May 9th
    11:30 AM – 12:15 PM CDT
    Efficacy Of SGLT-2 Inhibitors And GLP-1 Receptor Agonists In Patients With MASLD
    Location: Storyville Hall, Level 3
    Speaker: Aman Rajpal, MD, DABOM (he/him/his) – Alameda Health System
    Moderator: Kenneth Izuora, MD, MBA, FACE – University of Nevada Las Vegas
    Cardiometabolic and Lipids
  • Thursday, May 9th
    11:30 AM – 12:15 PM CDT
    MASLD and MASH: The New Nomenclature for Steatotic Liver Disease
    Location: Celestin D, Level 3
    Speaker: Scott Isaacs, MD, FACP, FACE (he/him/his) – Emory University School of Medicine
    Speaker: Sangeeta Kashyap, MD – Weill Cornell Medical Center
    Moderator: Betul Hatipoglu, MD (she/her/hers) – University Hospitals/Case Western Reserve University
    Cardiometabolic and Lipids
  • Friday, May 10th
    11:30 AM – 11:45 AM CDT
    Association Between Serum Lipoprotein (a), NAFLD and Risk of Non-fatal Myocardial Infarction in Individuals with Diabetes Mellitus
    Location: Collaboration Station, Empire Ballroom, Level 2
    Poster Presenter: Avica Atri, MD (she/her/hers) – Jefferson Albert Einstein Medical Center
    Cardiometabolic and Lipids
  • Friday, May 10th
    3:30 PM – 4:15 PM CDT
    DSN Year-in-Review: Cardiometabolic and Lipids Management
    Location: Celestin D, Level 3
    Speaker: Betul Hatipoglu, MD (she/her/hers) – University Hospitals/Case Western Reserve University
    Moderator: Cecilia C. Low Wang, MD – University of Colorado Anschutz Medical Campus School of Medicine
    Cardiometabolic and Lipids
  • Friday, May 10th
    4:45 PM – 5:45 PM CDT
    Refining Cardiovascular Risk Assessment in Clinical Practice: The Use of apoB, Lp(a), and Non-HDL Cholesterol
    Location: Celestin E, Level 3
    Speaker: Robert Eckel, Professor – University of Colorado Anschutz Medical Campus, Aurora, CO
    Speaker: Eliot A. Brinton, MD (he/him/his) – Utah Lipid Association
    Moderator: Betul Hatipoglu, MD (she/her/hers) – University Hospitals/Case Western Reserve University
    Cardiometabolic and Lipids
  • Saturday, May 11th
    1:15 PM – 2:15 PM CDT
    Managing the Patient with Severe Hypertriglyceridemia
    Location: Celestin D, Level 3
    Speaker: Maria Belalcazar, MD, FACE – University of Texas Medical Branch
    Moderator: Yumiko Tsushima, MD – Case Western Reserve University School Of Medicine
    Cardiometabolic and Lipids